How long does chemotherapy take to work for Waldenstrom macroglobulinaemia?

Waldenstrom macroglobulinaemia is a blood cancer involving abnormal lymphoplasmacytic cells and an abnormal immunoglobulin called IgM. Treatment can affect the amount of IgM and the symptoms caused by the disease, but these changes do not always occur at the same pace.

Your team may monitor blood counts, IgM and other blood measurements, along with fatigue, bleeding, headaches, vision changes, enlarged lymph nodes or other symptoms. The treatment plan may be continued while results are improving, even if you do not feel a sudden difference. The exact review schedule depends on the regimen and your health.

Attend every blood test and treatment review, and bring a list of symptoms, medicines and questions. Record changes in energy, headaches, vision, tingling, bleeding or infections. Do not stop treatment because a symptom has improved or because side effects are mild; the team needs the full picture to interpret the response safely.

Ask whether you need extra precautions during periods when blood counts are low. Take only supplements or non-prescription medicines that your care team has checked, because they may affect treatment or bleeding risk.

Seek urgent advice for new vision changes, severe headache, confusion, weakness, chest pain, breathlessness, uncontrolled bleeding, or fever and chills. These symptoms can need prompt assessment, particularly when blood thickness, infection or low blood counts may be concerns.

Ask which blood results will show response, when the first meaningful comparison is expected, what symptom changes require an urgent call, and what the next option would be if the results do not improve. Ask how your treatment schedule may change if blood counts fall.